AI in Healthcare Market Likely to Surpass ~USD 141 billion by 2035

Global AI in Healthcare Market Forecast 2035:

According to the report, the global AI in Healthcare market is likely to grow from USD 12.5 Billion in 2025 to USD 141 Billion in 2035 at a highest CAGR of 27.4% during the time period. Rapid growth in AI in healthcare market is taking place attributed to key trends, increasing digital health technology adoption, further, there is a growing amount of healthcare data, and there is an increased demand for accurate and efficient diagnostic processes. Thus, healthcare providers are increasingly using AI solutions to assist in the analysis of EHRs, images, and patient-generated data for improved clinical decision-making, operational efficiencies, and improved patient outcomes.

Additionally, telehealth services, remote monitoring of patients from home, and predictive analytics are expanding the use of AI in managing chronic disease and providing preventive care. Using a combination of AI tools such as machine learning, natural language processing (NLP), and wearables, healthcare providers now have access not only to tools that allow them to perform real-time diagnostics, however also to tools that can provide personalized treatment recommendations and optimize their operations across their hospitals, outpatient clinics, and other digital health platforms.

Key Driver, Restraint, and Growth Opportunity Shaping the Global AI in Healthcare Market

The global AI in healthcare market keeps expanding because hospitals and clinics use AI systems to automate their processes for diagnosing patients and evaluating their treatment needs. The integration of AI systems in digital health systems by healthcare organizations lets them analyze electronic health records and imaging scans and lab results and genomic data at an accelerated pace which helps improve clinical workflows and decrease mistakes while enabling doctors to make choices based on research evidence.

Notably, in 2025 Butterfly Network released its AI-powered handheld ultrasound system which enables doctors to detect medical abnormalities during actual patient assessment. Moreover, the US government maintained its extensive telehealth reimbursement system during 2025 which helped to boost remote artificial intelligence patient monitoring services.

Despite all, there are several factors delaying the AI in healthcare adoption including, stringent data privacy regulations and complex compliance requirements, as evidenced by continued enforcement of HIPAA and GDPR in 2025 which impacts AI clinical data projects; high implementation costs and integration challenges with legacy healthcare IT systems, as many hospitals reported delays to their AI EHR integration because of infrastructure upgrades occurring in 2024; limited technical expertise and no standardized AI frameworks exist at many healthcare facilities.

Additionally, the field of AI-driven predictive analytics and population health management offers strong potential because it facilitates the identification of diseases at early stages while providing customized treatment options and helping organizations manage their resources. AI technology now finds greater usage in pharmaceutical research through its application in drug discovery and clinical trial optimization and the monitoring of patient responses in real time.

AI technology has become essential for patient-centered healthcare delivery because it integrates with wearable devices and remote monitoring systems and telehealth platforms to support chronic disease management and preventive care and hospital operational efficiency and digital health system management.

Expansion of Global AI in Healthcare Market

Technological Innovation, Digital Health Integration, and Healthcare Infrastructure Investments Driving the Global AI in Healthcare Market Expansion

The global AI in healthcare market is witnessing rapid expansion because of three main factors which include new technological developments and digital health systems and healthcare infrastructure development funding. Artificial intelligence developments which include machine learning and deep learning and natural language processing research enable healthcare professionals to deliver customized patient treatment through improved diagnostic tools and predictive systems and clinical decision support systems.
Recently, Microsoft introduced AI-powered ambient documentation capabilities to its Dragon Copilot platform in 2025 which improved clinical workflow processes and decreased healthcare practitioners' administrative tasks. The increasing use of digital health technologies which include electronic health records and telemedicine and remote patient monitoring systems creates extensive data sources that AI uses for analysis while delivering immediate clinical insights.
Likewise, healthcare organizations are building stronger hospital networks and AI system development capabilities through the substantial funding which includes government support and private venture capital investments in healthcare IT infrastructure. The hospital sector in the United States raised its IT innovation expenditure by almost 20% between 2024 and 2024 to focus on acquiring AI-driven imaging systems and predictive analytics tools and workflow automation technologies.
The combination of technological progress and digital system integration and infrastructure development creates new market prospects which boost operational effectiveness and deliver better patient results and speed up AI in healthcare market systems throughout different regions of the world.

Regional Analysis of Global AI in Healthcare Market

The North America contains a very developed digital health system (ecosystem). Because of which, a lot of hospitals/health facilities have implemented electronic health records (EHRs), meaning they’re ready to use AI in other areas of healthcare like diagnostics, remote monitoring and predictive analytics, etc.
With the large number of people suffering from chronic illnesses, even more so when considering the established telemedicine reimbursement policies associated with Medicare (US citizens 65+ years old) and private insurances (for the remaining population) gives a big advantage to deploying AI within these areas.
Additionally, along with the many leading technology/healthcare companies in North America who are making significant investments to develop AI-powered clinical decision support systems, imaging technologies and workflow automation solutions, it will take a long time before other countries catch up with North America's share of AI in healthcare market.
The Asia Pacific region stands as the fastest expanding area for AI in healthcare because healthcare systems undergo digital transformation and people become more aware of telehealth services and there exists a requirement to enhance healthcare services in remote territories. India and China implement mobile health applications together with AI-based diagnostic tools and affordable digital health technologies to achieve better healthcare access for their entire populations.
The Indian government introduced the Ayushman Bharat Digital Mission program which combines AI telemedicine services with predictive analytics technology to provide healthcare services to millions of people. The region will experience growth because domestic startups increase their investments and establish partnerships with international AI healthcare companies, which will make Asia Pacific the fastest expanding AI in healthcare market across the world.

Prominent players operating in global AI in healthcare market include prominent companies such as Amazon Web Services, Inc., Cloudmedx Inc., Enlitic, Inc., GE HealthCare Technologies Inc., Google LLC, Hewlett Packard Enterprise Company, Intel Corporation, International Business Machines Corporation, IQVIA Holdings Inc., Johnson & Johnson, Koninklijke Philips N.V., Lunit Inc., Medtronic plc, Microsoft Corporation, NVIDIA Corporation, Oncora Medical, Inc., Oracle Corporation, Siemens Healthineers AG, UnitedHealth Group Incorporated, Veradigm LLC, along with several other key players.

The global AI in healthcare market has been segmented as follows:

Global AI in Healthcare Market Analysis, by Component

Hardware
- AI-Enabled Medical Devices
- AI-Integrated Imaging Systems
- Edge Computing Devices
Software
- AI Platforms
- AI Healthcare Applications
- Clinical Decision Support Software
Services
- Deployment & Integration Services
- Consulting Services
- Maintenance & Support Services

Global AI in Healthcare Market Analysis, by Technology

Machine Learning
- Supervised Learning
- Unsupervised Learning
- Reinforcement Learning
Deep Learning
Natural Language Processing (NLP)
Computer Vision
Context-Aware Computing
Predictive Analytics
Others

Global AI in Healthcare Market Analysis, by Deployment Mode

Cloud-Based Deployment
- Public Cloud
- Private Cloud
- Hybrid Cloud
On-Premise Deployment

Global AI in Healthcare Market Analysis, by Therapeutic Area

Oncology
Cardiology
Neurology
Respiratory Diseases
Dermatology
Orthopedics
Mental Health
Endocrinology
Infectious Diseases
Others

Global AI in Healthcare Market Analysis, by Data Type

Medical Imaging Data
Electronic Health Records (EHR) Data
Genomic Data
Wearable and Sensor Data
Clinical Trial Data
Others

Global AI in Healthcare Market Analysis, by Application

Medical Imaging and Diagnostics
Drug Discovery and Development
Personalized Treatment and Precision Medicine
Clinical Trials Optimization
Virtual Health Assistants
Hospital Workflow Management
Remote Patient Monitoring
Fraud Detection and Cybersecurity
Others

Global AI in Healthcare Market Analysis, by End User

Hospitals and Healthcare Providers
Pharmaceutical and Biotechnology Companies
Healthcare Payers
Clinical Research Organizations
Patients
Government and Public Health Agencies
Others

Global AI in Healthcare Market Analysis, by Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Natures
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Natures
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global AI in Healthcare Market Outlook
  - 2.1.1. AI in Healthcare Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2026-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
  - 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Rising healthcare data volumes enabling AI-driven diagnostics and predictive analytics.
    - 4.1.1.2. Increasing adoption of telemedicine, remote patient monitoring, and digital health platforms.
    - 4.1.1.3. Growing demand for accurate, efficient, and personalized patient care solutions.
  - 4.1.2. Restraints
    - 4.1.2.1. Stringent data privacy regulations and complex compliance requirements limiting AI deployment.
    - 4.1.2.2. High implementation costs and integration challenges with legacy healthcare IT systems.
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
  - 4.4.1. System Integrators/ Technology Providers
  - 4.4.2. AI in Healthcare Solution Providers
  - 4.4.3. End Users
- 4.5. Cost Structure Analysis
- 4.6. Porter’s Five Forces Analysis
- 4.7. PESTEL Analysis
- 4.8. Global AI in Healthcare Market Demand
  - 4.8.1. Historical Market Size – Value (US$ Bn), 2020-2024
  - 4.8.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
    - 4.8.2.1. Y-o-Y Growth Trends
    - 4.8.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global AI in Healthcare Market Analysis, by Component
- 6.1. Key Segment Analysis
- 6.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
  - 6.2.1. Hardware
    - 6.2.1.1. AI-Enabled Medical Devices
    - 6.2.1.2. AI-Integrated Imaging Systems
    - 6.2.1.3. Edge Computing Devices
  - 6.2.2. Software
    - 6.2.2.1. AI Platforms
    - 6.2.2.2. AI Healthcare Applications
    - 6.2.2.3. Clinical Decision Support Software
  - 6.2.3. Services
    - 6.2.3.1. Deployment & Integration Services
    - 6.2.3.2. Consulting Services
    - 6.2.3.3. Maintenance & Support Services
7. Global AI in Healthcare Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
  - 7.2.1. Machine Learning
    - 7.2.1.1. Supervised Learning
    - 7.2.1.2. Unsupervised Learning
    - 7.2.1.3. Reinforcement Learning
  - 7.2.2. Deep Learning
  - 7.2.3. Natural Language Processing (NLP)
  - 7.2.4. Computer Vision
  - 7.2.5. Context-Aware Computing
  - 7.2.6. Predictive Analytics
  - 7.2.7. Others
8. Global AI in Healthcare Market Analysis, by Deployment Mode
- 8.1. Key Segment Analysis
- 8.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
  - 8.2.1. Cloud-Based Deployment
    - 8.2.1.1. Public Cloud
    - 8.2.1.2. Private Cloud
    - 8.2.1.3. Hybrid Cloud
  - 8.2.2. On-Premise Deployment
9. Global AI in Healthcare Market Analysis, by Therapeutic Area
- 9.1. Key Segment Analysis
- 9.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapeutic Area, 2021-2035
  - 9.2.1. Oncology
  - 9.2.2. Cardiology
  - 9.2.3. Neurology
  - 9.2.4. Respiratory Diseases
  - 9.2.5. Dermatology
  - 9.2.6. Orthopedics
  - 9.2.7. Mental Health
  - 9.2.8. Endocrinology
  - 9.2.9. Infectious Diseases
  - 9.2.10. Others
10. Global AI in Healthcare Market Analysis, by Data Type
- 10.1. Key Segment Analysis
- 10.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by Data Type, 2021-2035
  - 10.2.1. Medical Imaging Data
  - 10.2.2. Electronic Health Records (EHR) Data
  - 10.2.3. Genomic Data
  - 10.2.4. Wearable and Sensor Data
  - 10.2.5. Clinical Trial Data
  - 10.2.6. Others
11. Global AI in Healthcare Market Analysis, by Application
- 11.1. Key Segment Analysis
- 11.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
  - 11.2.1. Medical Imaging and Diagnostics
  - 11.2.2. Drug Discovery and Development
  - 11.2.3. Personalized Treatment and Precision Medicine
  - 11.2.4. Clinical Trials Optimization
  - 11.2.5. Virtual Health Assistants
  - 11.2.6. Hospital Workflow Management
  - 11.2.7. Remote Patient Monitoring
  - 11.2.8. Fraud Detection and Cybersecurity
  - 11.2.9. Others
12. Global AI in Healthcare Market Analysis, by End User
- 12.1. Key Segment Analysis
- 12.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
  - 12.2.1. Hospitals and Healthcare Providers
  - 12.2.2. Pharmaceutical and Biotechnology Companies
  - 12.2.3. Healthcare Payers
  - 12.2.4. Clinical Research Organizations
  - 12.2.5. Patients
  - 12.2.6. Government and Public Health Agencies
  - 12.2.7. Others
13. Global AI in Healthcare Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
  - 13.2.1. North America
  - 13.2.2. Europe
  - 13.2.3. Asia Pacific
  - 13.2.4. Middle East
  - 13.2.5. Africa
  - 13.2.6. South America
14. North America AI in Healthcare Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 14.3.1. Component
  - 14.3.2. Technology
  - 14.3.3. Deployment Mode
  - 14.3.4. Therapeutic Area
  - 14.3.5. Data Type
  - 14.3.6. Application
  - 14.3.7. End User
  - 14.3.8. Country
    - 14.3.8.1. USA
    - 14.3.8.2. Canada
    - 14.3.8.3. Mexico
- 14.4. USA AI in Healthcare Market
  - 14.4.1. Country Segmental Analysis
  - 14.4.2. Component
  - 14.4.3. Technology
  - 14.4.4. Deployment Mode
  - 14.4.5. Therapeutic Area
  - 14.4.6. Data Type
  - 14.4.7. Application
  - 14.4.8. End User
- 14.5. Canada AI in Healthcare Market
  - 14.5.1. Country Segmental Analysis
  - 14.5.2. Component
  - 14.5.3. Technology
  - 14.5.4. Deployment Mode
  - 14.5.5. Therapeutic Area
  - 14.5.6. Data Type
  - 14.5.7. Application
  - 14.5.8. End User
- 14.6. Mexico AI in Healthcare Market
  - 14.6.1. Country Segmental Analysis
  - 14.6.2. Component
  - 14.6.3. Technology
  - 14.6.4. Deployment Mode
  - 14.6.5. Therapeutic Area
  - 14.6.6. Data Type
  - 14.6.7. Application
  - 14.6.8. End User
15. Europe AI in Healthcare Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 15.3.1. Component
  - 15.3.2. Technology
  - 15.3.3. Deployment Mode
  - 15.3.4. Therapeutic Area
  - 15.3.5. Data Type
  - 15.3.6. Application
  - 15.3.7. End User
  - 15.3.8. Country
    - 15.3.8.1. Germany
    - 15.3.8.2. United Kingdom
    - 15.3.8.3. France
    - 15.3.8.4. Italy
    - 15.3.8.5. Spain
    - 15.3.8.6. Netherlands
    - 15.3.8.7. Nordic Countries
    - 15.3.8.8. Poland
    - 15.3.8.9. Russia & CIS
    - 15.3.8.10. Rest of Europe
- 15.4. Germany AI in Healthcare Market
  - 15.4.1. Country Segmental Analysis
  - 15.4.2. Component
  - 15.4.3. Technology
  - 15.4.4. Deployment Mode
  - 15.4.5. Therapeutic Area
  - 15.4.6. Data Type
  - 15.4.7. Application
  - 15.4.8. End User
- 15.5. United Kingdom AI in Healthcare Market
  - 15.5.1. Country Segmental Analysis
  - 15.5.2. Component
  - 15.5.3. Technology
  - 15.5.4. Deployment Mode
  - 15.5.5. Therapeutic Area
  - 15.5.6. Data Type
  - 15.5.7. Application
  - 15.5.8. End User
- 15.6. France AI in Healthcare Market
  - 15.6.1. Country Segmental Analysis
  - 15.6.2. Component
  - 15.6.3. Technology
  - 15.6.4. Deployment Mode
  - 15.6.5. Therapeutic Area
  - 15.6.6. Data Type
  - 15.6.7. Application
  - 15.6.8. End User
- 15.7. Italy AI in Healthcare Market
  - 15.7.1. Country Segmental Analysis
  - 15.7.2. Component
  - 15.7.3. Technology
  - 15.7.4. Deployment Mode
  - 15.7.5. Therapeutic Area
  - 15.7.6. Data Type
  - 15.7.7. Application
  - 15.7.8. End User
- 15.8. Spain AI in Healthcare Market
  - 15.8.1. Country Segmental Analysis
  - 15.8.2. Component
  - 15.8.3. Technology
  - 15.8.4. Deployment Mode
  - 15.8.5. Therapeutic Area
  - 15.8.6. Data Type
  - 15.8.7. Application
  - 15.8.8. End User
- 15.9. Netherlands AI in Healthcare Market
  - 15.9.1. Country Segmental Analysis
  - 15.9.2. Component
  - 15.9.3. Technology
  - 15.9.4. Deployment Mode
  - 15.9.5. Therapeutic Area
  - 15.9.6. Data Type
  - 15.9.7. Application
  - 15.9.8. End User
- 15.10. Nordic Countries AI in Healthcare Market
  - 15.10.1. Country Segmental Analysis
  - 15.10.2. Component
  - 15.10.3. Technology
  - 15.10.4. Deployment Mode
  - 15.10.5. Therapeutic Area
  - 15.10.6. Data Type
  - 15.10.7. Application
  - 15.10.8. End User
- 15.11. Poland AI in Healthcare Market
  - 15.11.1. Country Segmental Analysis
  - 15.11.2. Component
  - 15.11.3. Technology
  - 15.11.4. Deployment Mode
  - 15.11.5. Therapeutic Area
  - 15.11.6. Data Type
  - 15.11.7. Application
  - 15.11.8. End User
- 15.12. Russia & CIS AI in Healthcare Market
  - 15.12.1. Country Segmental Analysis
  - 15.12.2. Component
  - 15.12.3. Technology
  - 15.12.4. Deployment Mode
  - 15.12.5. Therapeutic Area
  - 15.12.6. Data Type
  - 15.12.7. Application
  - 15.12.8. End User
- 15.13. Rest of Europe AI in Healthcare Market
  - 15.13.1. Country Segmental Analysis
  - 15.13.2. Component
  - 15.13.3. Technology
  - 15.13.4. Deployment Mode
  - 15.13.5. Therapeutic Area
  - 15.13.6. Data Type
  - 15.13.7. Application
  - 15.13.8. End User
16. Asia Pacific AI in Healthcare Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Asia Pacific AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Component
  - 16.3.2. Technology
  - 16.3.3. Deployment Mode
  - 16.3.4. Therapeutic Area
  - 16.3.5. Data Type
  - 16.3.6. Application
  - 16.3.7. End User
  - 16.3.8. Country
    - 16.3.8.1. China
    - 16.3.8.2. India
    - 16.3.8.3. Japan
    - 16.3.8.4. South Korea
    - 16.3.8.5. Australia and New Zealand
    - 16.3.8.6. Indonesia
    - 16.3.8.7. Malaysia
    - 16.3.8.8. Thailand
    - 16.3.8.9. Vietnam
    - 16.3.8.10. Rest of Asia Pacific
- 16.4. China AI in Healthcare Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Component
  - 16.4.3. Technology
  - 16.4.4. Deployment Mode
  - 16.4.5. Therapeutic Area
  - 16.4.6. Data Type
  - 16.4.7. Application
  - 16.4.8. End User
- 16.5. India AI in Healthcare Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Component
  - 16.5.3. Technology
  - 16.5.4. Deployment Mode
  - 16.5.5. Therapeutic Area
  - 16.5.6. Data Type
  - 16.5.7. Application
  - 16.5.8. End User
- 16.6. Japan AI in Healthcare Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Component
  - 16.6.3. Technology
  - 16.6.4. Deployment Mode
  - 16.6.5. Therapeutic Area
  - 16.6.6. Data Type
  - 16.6.7. Application
  - 16.6.8. End User
- 16.7. South Korea AI in Healthcare Market
  - 16.7.1. Country Segmental Analysis
  - 16.7.2. Component
  - 16.7.3. Technology
  - 16.7.4. Deployment Mode
  - 16.7.5. Therapeutic Area
  - 16.7.6. Data Type
  - 16.7.7. Application
  - 16.7.8. End User
- 16.8. Australia and New Zealand AI in Healthcare Market
  - 16.8.1. Country Segmental Analysis
  - 16.8.2. Component
  - 16.8.3. Technology
  - 16.8.4. Deployment Mode
  - 16.8.5. Therapeutic Area
  - 16.8.6. Data Type
  - 16.8.7. Application
  - 16.8.8. End User
- 16.9. Indonesia AI in Healthcare Market
  - 16.9.1. Country Segmental Analysis
  - 16.9.2. Component
  - 16.9.3. Technology
  - 16.9.4. Deployment Mode
  - 16.9.5. Therapeutic Area
  - 16.9.6. Data Type
  - 16.9.7. Application
  - 16.9.8. End User
- 16.10. Malaysia AI in Healthcare Market
  - 16.10.1. Country Segmental Analysis
  - 16.10.2. Component
  - 16.10.3. Technology
  - 16.10.4. Deployment Mode
  - 16.10.5. Therapeutic Area
  - 16.10.6. Data Type
  - 16.10.7. Application
  - 16.10.8. End User
- 16.11. Thailand AI in Healthcare Market
  - 16.11.1. Country Segmental Analysis
  - 16.11.2. Component
  - 16.11.3. Technology
  - 16.11.4. Deployment Mode
  - 16.11.5. Therapeutic Area
  - 16.11.6. Data Type
  - 16.11.7. Application
  - 16.11.8. End User
- 16.12. Vietnam AI in Healthcare Market
  - 16.12.1. Country Segmental Analysis
  - 16.12.2. Component
  - 16.12.3. Technology
  - 16.12.4. Deployment Mode
  - 16.12.5. Therapeutic Area
  - 16.12.6. Data Type
  - 16.12.7. Application
  - 16.12.8. End User
- 16.13. Rest of Asia Pacific AI in Healthcare Market
  - 16.13.1. Country Segmental Analysis
  - 16.13.2. Component
  - 16.13.3. Technology
  - 16.13.4. Deployment Mode
  - 16.13.5. Therapeutic Area
  - 16.13.6. Data Type
  - 16.13.7. Application
  - 16.13.8. End User
17. Middle East AI in Healthcare Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Component
  - 17.3.2. Technology
  - 17.3.3. Deployment Mode
  - 17.3.4. Therapeutic Area
  - 17.3.5. Data Type
  - 17.3.6. Application
  - 17.3.7. End User
  - 17.3.8. Country
    - 17.3.8.1. Turkey
    - 17.3.8.2. UAE
    - 17.3.8.3. Saudi Arabia
    - 17.3.8.4. Israel
    - 17.3.8.5. Rest of Middle East
- 17.4. Turkey AI in Healthcare Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Component
  - 17.4.3. Technology
  - 17.4.4. Deployment Mode
  - 17.4.5. Therapeutic Area
  - 17.4.6. Data Type
  - 17.4.7. Application
  - 17.4.8. End User
- 17.5. UAE AI in Healthcare Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Component
  - 17.5.3. Technology
  - 17.5.4. Deployment Mode
  - 17.5.5. Therapeutic Area
  - 17.5.6. Data Type
  - 17.5.7. Application
  - 17.5.8. End User
- 17.6. Saudi Arabia AI in Healthcare Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Component
  - 17.6.3. Technology
  - 17.6.4. Deployment Mode
  - 17.6.5. Therapeutic Area
  - 17.6.6. Data Type
  - 17.6.7. Application
  - 17.6.8. End User
- 17.7. Israel AI in Healthcare Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Component
  - 17.7.3. Technology
  - 17.7.4. Deployment Mode
  - 17.7.5. Therapeutic Area
  - 17.7.6. Data Type
  - 17.7.7. Application
  - 17.7.8. End User
- 17.8. Rest of Middle East AI in Healthcare Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Component
  - 17.8.3. Technology
  - 17.8.4. Deployment Mode
  - 17.8.5. Therapeutic Area
  - 17.8.6. Data Type
  - 17.8.7. Application
  - 17.8.8. End User
18. Africa AI in Healthcare Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Component
  - 18.3.2. Technology
  - 18.3.3. Deployment Mode
  - 18.3.4. Therapeutic Area
  - 18.3.5. Data Type
  - 18.3.6. Application
  - 18.3.7. End User
  - 18.3.8. Country
    - 18.3.8.1. South Africa
    - 18.3.8.2. Egypt
    - 18.3.8.3. Nigeria
    - 18.3.8.4. Algeria
    - 18.3.8.5. Rest of Africa
- 18.4. South Africa AI in Healthcare Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Component
  - 18.4.3. Technology
  - 18.4.4. Deployment Mode
  - 18.4.5. Therapeutic Area
  - 18.4.6. Data Type
  - 18.4.7. Application
  - 18.4.8. End User
- 18.5. Egypt AI in Healthcare Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Component
  - 18.5.3. Technology
  - 18.5.4. Deployment Mode
  - 18.5.5. Therapeutic Area
  - 18.5.6. Data Type
  - 18.5.7. Application
  - 18.5.8. End User
- 18.6. Nigeria AI in Healthcare Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Component
  - 18.6.3. Technology
  - 18.6.4. Deployment Mode
  - 18.6.5. Therapeutic Area
  - 18.6.6. Data Type
  - 18.6.7. Application
  - 18.6.8. End User
- 18.7. Algeria AI in Healthcare Market
  - 18.7.1. Country Segmental Analysis
  - 18.7.2. Component
  - 18.7.3. Technology
  - 18.7.4. Deployment Mode
  - 18.7.5. Therapeutic Area
  - 18.7.6. Data Type
  - 18.7.7. Application
  - 18.7.8. End User
- 18.8. Rest of Africa AI in Healthcare Market
  - 18.8.1. Country Segmental Analysis
  - 18.8.2. Component
  - 18.8.3. Technology
  - 18.8.4. Deployment Mode
  - 18.8.5. Therapeutic Area
  - 18.8.6. Data Type
  - 18.8.7. Application
  - 18.8.8. End User
19. South America AI in Healthcare Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. South America AI in Healthcare Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 19.3.1. Component
  - 19.3.2. Technology
  - 19.3.3. Deployment Mode
  - 19.3.4. Therapeutic Area
  - 19.3.5. Data Type
  - 19.3.6. Application
  - 19.3.7. End User
  - 19.3.8. Country
    - 19.3.8.1. Brazil
    - 19.3.8.2. Argentina
    - 19.3.8.3. Rest of South America
- 19.4. Brazil AI in Healthcare Market
  - 19.4.1. Country Segmental Analysis
  - 19.4.2. Component
  - 19.4.3. Technology
  - 19.4.4. Deployment Mode
  - 19.4.5. Therapeutic Area
  - 19.4.6. Data Type
  - 19.4.7. Application
  - 19.4.8. End User l
- 19.5. Argentina AI in Healthcare Market
  - 19.5.1. Country Segmental Analysis
  - 19.5.2. Component
  - 19.5.3. Technology
  - 19.5.4. Deployment Mode
  - 19.5.5. Therapeutic Area
  - 19.5.6. Data Type
  - 19.5.7. Application
  - 19.5.8. End User
- 19.6. Rest of South America AI in Healthcare Market
  - 19.6.1. Country Segmental Analysis
  - 19.6.2. Component
  - 19.6.3. Technology
  - 19.6.4. Deployment Mode
  - 19.6.5. Therapeutic Area
  - 19.6.6. Data Type
  - 19.6.7. Application
  - 19.6.8. End User
20. Key Players/ Company Profile
- 20.1. Amazon Web Services, Inc.
  - 20.1.1. Company Details/ Overview
  - 20.1.2. Company Financials
  - 20.1.3. Key Customers and Competitors
  - 20.1.4. Business/ Industry Portfolio
  - 20.1.5. Product Portfolio/ Specification Details
  - 20.1.6. Pricing Data
  - 20.1.7. Strategic Overview
  - 20.1.8. Recent Developments
- 20.2. Cloudmedx Inc.
- 20.3. Enlitic, Inc.
- 20.4. GE HealthCare Technologies Inc.
- 20.5. Google LLC
- 20.6. Hewlett Packard Enterprise Company
- 20.7. Intel Corporation
- 20.8. International Business Machines Corporation
- 20.9. IQVIA Holdings Inc.
- 20.10. Johnson & Johnson
- 20.11. Koninklijke Philips N.V.
- 20.12. Lunit Inc.
- 20.13. Medtronic plc
- 20.14. Microsoft Corporation
- 20.15. NVIDIA Corporation
- 20.16. Oncora Medical, Inc.
- 20.17. Oracle Corporation
- 20.18. Siemens Healthineers AG
- 20.19. UnitedHealth Group Incorporated
- 20.20. Veradigm LLC
- 20.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation